Stocks making the biggest moves midday: Uber, Apple, Lyft, Caterpillar & more

Lyft– Shares of ride-sharing company tanked as much as 7% leading up to and after Uber’s initial public offering Friday. Lyft and Uber are the two most …

Check out the companies making headlines in midday trade Friday:

Uber– Shares of Uber were mostly down during its first hour of trading after going public on the New York Stock Exchange on Friday. Uber opened at $42 a share, lower than the $45 it was priced at on Thursday night.

Lyft– Shares of ride-sharing company tanked as much as 7% leading up to and after Uber’s initial public offering Friday. Lyft and Uber are the two most dominant companies in the ride sharing business. Lyft’s stock is down about 30% since its IPO at the end of March.

Apple– Apple’s stock fell 3% and was down as much as 9% for the week on Friday. The iPhone maker is viewed as particularly vulnerable to the recent escalation in the trade war given its dependence on China for production and sales.

Caterpillar– Shares of the construction company fell 2% amid the escalated trade tensions with China.

Marriott– Shares of the hotel company fell 5% following mixed first-quarter earnings released Friday. Marriott reported adjusted earnings per share of $1.41, beating the estimated $1.34, according to Refinitiv. Revenue was $5.01 billion, missing the expected $5.11 billion.

Yelp- Shares of recommendation website Yelp plummeted 13% Friday after the company gave weak second-quarter guidance a day earlier. Yelp said for the second quarter it estimates revenue will increase between 4% and 6%, lower than the expected increase of 6.6%, per Refinitiv.

Booking Holdings– The booking company jumped about 3% despite missing on the top and bottom lines in its first-quarter earnings after the bell Thursday. Booking Holdings reported earnings per share of $11.17 on revenue of of $2.84 billion. Wall Street estimated earnings per share of $11.27 on revenue of $2.93 billion, according to Refinitiv.

Zillow– Shares of the home-finder website surged 6% after posting better-than-expected first-quarter earnings Thursday. Zillow reported a loss of 33 cents per share, compared to the loss of 35 cents per share analysts were expecting per Refinitiv.

News Corp.- Shares jumped 4% on Friday after the company reported a surprise quarterly profit in its third quarter, driven by growth in book publishing. The company reported earnings per share of 4 cents on revenue of $2.46 billion. Wall Street estimated earnings per share of 0 cents on revenue of $2.51 billion, according to Refinitiv.

Equifax– Shares of Equifax fell 2% after the company missed on revenue in its first-quarter results. Revenue was $846.1 million, lower than the expected $848.9 million, according to Refinitiv. Earnings per share came in line with estimates at $1.20 per share.

—CNBC’s Matt Lavietescontributed to this report.

Related Posts:

  • No Related Posts

NXP Semiconductors NV (NASDAQ: NXPI): Its Up In The Air But Definitely Not Out:

Intraday Trading of NXP Semiconductors N.V.: If one intends to pursue a career as a trader, then one must understand and choose between two basic …

Intraday Trading of NXP Semiconductors N.V.:

If one intends to pursue a career as a trader, then one must understand and choose between two basic categories of trading i.e. day trading vs swing trading. Nevertheless, the eventual aim in the case of a day trader or a swing trader remains the same which is to generate profits.

However, the holding period and the technical tools which are being used to achieve the ultimate aim differ between the two classes of traders which will be the topic of discussion in this article. Besides, there are several other factors which a trader needs to take into account in order to select the conducive trading strategy and these factors include (not exhaustive) time invested, personality trait, size of the account, trader skill level and level of commitment among others.

The Technology stock closed its last trading at $100.33 while performing a change of -1.15% on 09-05-2019 (Thursday).

Notable Indicators to Watch:

NXP Semiconductors N.V., a Netherlands based Company, belongs to Technology sector and Semiconductor – Broad Line industry. The NXP Semiconductors N.V. has the market capitalization of $32.54B.

Its EPS was $6.85 while outstanding shares of the company were 324.32M. Shares outstanding are all the shares of a corporation or financial asset that have been authorized, issued and purchased by investors and are held by them. They have rights and represent ownership in the corporation by the person who holds the shares.

  • The number of stocks outstanding is equal to the number of issued shares minus the number of shares held in the company’s treasury.
  • It’s also equal to the float (shares available to the public and excludes any restricted shares, or shares held by company officers or insiders) plus any restricted shares.

Performance Review:

To clear the blur picture shareholders will need to look a little deeper. The NXP Semiconductors N.V. has shown a weekly performance of -5.88% and monthly performance stands at 2.81%.

The stock has shown a quarterly performance of 10.58% and a half-year performance stands at 21.08%. Analyst recommendation for this stock stands at 2.3.

Technical Analysis of NXP Semiconductors N.V.:

ATR stands at 3.37 while a Beta factor of the stock stands at 1.11. As a result, the company has an (Earning per Share) EPS growth of 18.46% for the coming year. Company’s EPS for the prior five-years is valued at 37.5%, leading it to an EPS value of 11.35% for the next five years.

  • When you analyze a company’s financial health, the very first measure that you may want to check is profitability.
  • The portion of a company’s profit allocated to each outstanding share of common stock is known as Earnings Per Share or EPS.
  • Though the interpretation of Earnings Per Share is relatively easy, however, the EPS calculation is not this simple.
  • Volatility is a statistical measure of the dispersion of returns for a given security or market index.

Volatility can either be measured by using the standard deviation or variance between returns from that same security or market index.

The NXP Semiconductors N.V. remained 3.19% volatile for recent the week and 2.69% for the current month. The price target set for the stock is $103.68, and this sets up an impressive set of potential movement for the stock.

Profitability Ratios:

Looking into the profitability ratios of NXPI stock, the investor will find its ROE, ROA, ROI standing at 18.2%, 9.9% and 13.7%, respectively. The current relative strength index (RSI) reading is 49.62.

SMA (Simple Moving Average):

Its distance from 20 days simple moving average is -0.92%, and its distance from 50 days simple moving average is 4.26% while it has a distance of 14.03% from the 200 days simple moving average.

The company’s distance from 52-week high price is -17.92% and while current price is 48.37% from 52-week low price. As of now, NXP Semiconductors N.V. has a P/S, P/E and P/B values of 3.46, 14.64 and 2.8 respectively. The NXPI has PEG of 1.29.

Post Views: 19

Related Posts:

  • No Related Posts

IRIDEX Co. (IRIX) Expected to Announce Earnings of -$0.22 Per Share

Zacks Investment Research’s earnings per share calculations are an … Quantum Capital Management grew its position in shares of IRIDEX by 83.2% …

IRIDEX logoBrokerages expect IRIDEX Co. (NASDAQ:IRIX) to post ($0.22) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for IRIDEX’s earnings. IRIDEX posted earnings per share of ($0.28) during the same quarter last year, which indicates a positive year over year growth rate of 21.4%. The company is expected to report its next quarterly earnings results on Thursday, August 1st.

On average, analysts expect that IRIDEX will report full year earnings of ($0.82) per share for the current year, with EPS estimates ranging from ($0.85) to ($0.79). For the next fiscal year, analysts anticipate that the company will report earnings of ($0.47) per share, with EPS estimates ranging from ($0.50) to ($0.44). Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that cover IRIDEX.

IRIDEX (NASDAQ:IRIX) last posted its earnings results on Thursday, May 2nd. The medical equipment provider reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.24) by $0.02. The company had revenue of $10.60 million during the quarter, compared to the consensus estimate of $10.46 million. IRIDEX had a negative net margin of 28.06% and a negative return on equity of 42.27%.

IRIX has been the subject of several recent research reports. Roth Capital reissued a “buy” rating on shares of IRIDEX in a research report on Tuesday, February 5th. Zacks Investment Research downgraded shares of IRIDEX from a “hold” rating to a “sell” rating in a research report on Friday, March 8th.

Hedge funds have recently modified their holdings of the business. Gabelli Funds LLC bought a new stake in IRIDEX in the 1st quarter worth about $46,000. Stifel Financial Corp bought a new stake in IRIDEX in the 4th quarter worth about $66,000. Neuberger Berman Group LLC grew its position in shares of IRIDEX by 60.0% during the 3rd quarter. Neuberger Berman Group LLC now owns 24,000 shares of the medical equipment provider’s stock valued at $152,000 after acquiring an additional 9,000 shares during the period. Quantum Capital Management grew its position in shares of IRIDEX by 83.2% during the 4th quarter. Quantum Capital Management now owns 28,829 shares of the medical equipment provider’s stock valued at $135,000 after acquiring an additional 13,089 shares during the period. Finally, FineMark National Bank & Trust grew its position in shares of IRIDEX by 27.5% during the 1st quarter. FineMark National Bank & Trust now owns 39,365 shares of the medical equipment provider’s stock valued at $180,000 after acquiring an additional 8,500 shares during the period. 44.23% of the stock is owned by institutional investors and hedge funds.

NASDAQ:IRIX opened at $5.24 on Tuesday. The stock has a market cap of $69.53 million, a PE ratio of -4.99 and a beta of 1.05. IRIDEX has a one year low of $3.72 and a one year high of $9.48.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser systems, which are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.

Featured Story: Bar Chart

Get a free copy of the Zacks research report on IRIDEX (IRIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for IRIDEX Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for IRIDEX and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

NHC Reports First Quarter 2019 Earnings

Excluding the unrealized gains and losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the …

MURFREESBORO, Tenn.–(BUSINESS WIRE)–

National HealthCare Corporation (NYSE American: NHC), the nation’s oldest publicly traded senior health care company, announced today net operating revenues for the quarter ended March 31, 2019 totaled $248,285,000 compared to $242,961,000 for the quarter ended March 31, 2018, an increase of 2.2%.

For the quarter ended March 31, 2019, the reported GAAP net income attributable to NHC was $21,269,000 compared to a GAAP net loss attributable to NHC of $2,791,000 for the first quarter of 2018. Excluding the unrealized gains and losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended March 31, 2019 was $16,951,000 compared to $16,362,000 for the first quarter of 2018, an increase of 3.6% (*). For the quarter ended March 31, 2019, the reported GAAP diluted earnings per share was $1.39 compared to a GAAP diluted loss per share of $0.18 for the first quarter of 2018. The adjusted diluted earnings per share was $1.11 for the quarter ended March 31, 2019, compared to $1.08 for the first quarter of 2018 (*).

(*) – See the tables below that provide a reconciliation of GAAP to non-GAAP items.

About NHC

NHC affiliates operate for themselves and third parties 75 skilled nursing facilities with 9,510 beds. NHC affiliates also operate 25 assisted living communities, five independent living communities, one behavioral health hospital and 35 homecare programs. NHC’s other services include Alzheimer’s and memory care units, hospice services, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Forward-Looking Statements

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q and 10-K, and include, among others, the following: liabilities and other claims asserted against us and patient care liabilities, as well as the resolution of current litigation; availability of insurance and assets for indemnification; national and local economic conditions; including their effect on the availability and cost of labor, utilities and materials; the effect of government regulations and changes in regulations governing the healthcare industry, including our compliance with such regulations; changes in Medicare and Medicaid payment levels and methodologies and the application of such methodologies by the government and its fiscal intermediaries; and other factors referenced or incorporated by reference in the S.E.C. filings. The risks included here are not exhaustive. All forward-looking statements represent NHC’s best judgment as of the date of this release.

Consolidated Statements of Income
(in thousands, except share and per share amounts)
Three Months Ended
March 31
2019 2018
(unaudited)
Revenues:
Net patient revenues $ 236,111 $ 231,692
Other revenues 12,174 11,269
Net operating revenues 248,285 242,961
Costs and expenses:
Salaries, wages and benefits 141,388 140,095
Other operating 69,432 65,172
Facility rent 10,238 10,229
Depreciation and amortization 10,517 10,342
Interest 926 1,240
Total costs and expenses 232,501 227,078
Income from operations 15,784 15,883
Non-operating income (loss) 6,001 (3,065 )
Unrealized gains/(losses) on marketable equity securities 6,838 (15,517 )
Income (loss) before income taxes 28,623 (2,699 )
Income tax provision (7,392 ) (200 )
Net income (loss) 21,231 (2,899 )
Net loss attributable to noncontrolling interest 38 108
Net income (loss) attributable to National HealthCare Corporation $ 21,269 $ (2,791 )
Net income (loss) per common share
Basic $ 1.39 $ (0.18 )
Diluted $ 1.39 $ (0.18 )
Weighted average common shares outstanding
Basic 15,256,189 15,216,635
Diluted 15,324,125 15,216,635
Dividends declared per common share $ 0.50 $ 0.48
Balance Sheet Data
(in thousands) March 31 Dec. 31
2019 2018
(unaudited)
Cash, cash equivalents and marketable equity securities $ 185,255 $ 183,470
Restricted cash, cash equivalents and marketable debt securities 189,312 184,266
Current assets 327,113 322,009
Property and equipment, net 532,804 534,650
Total assets 1,312,297 1,080,948
Current liabilities 169,962 157,924
Long-term debt 55,000 55,000
NHC stockholders’ equity 749,574 733,278
Selected Operating Statistics
Three Months Ended
March 31
2019

2018(1)

(unaudited)
Skilled Nursing Per Diems:
Medicare $ 461.50 $ 461.55
Managed Care 395.50 401.74
Medicaid 195.89 189.88
Private Pay and Other 245.76 238.88
Average Skilled Nursing Per Diem $ 272.40 $ 273.39
Skilled Nursing Patient Days:

Medicare

112,854 126,127
Managed Care 62,427 60,126
Medicaid 318,286 304,504
Private Pay and Other 175,356 174,442
Total Skilled Nursing Patient Days 668,923 665,199

(1) A skilled nursing facility in Madisonville, Kentucky was sold in the fourth quarter of 2018. The per diems and patient days for this facility have been excluded in the 2018 column for comparative purposes.

The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts):

Three Months Ended
March 31
2019 2018
(unaudited)
Net income (loss) attributable to National Healthcare Corporation $ 21,269 $ (2,791 )
Non-GAAP adjustments
Unrealized (gains)/losses on marketable equity securities (6,838 ) 15,517
Legal costs and charges related to Caris’ legal investigation 8,228
Operating results for newly opened facilities not at full capacity (2) 595 555
Stock-based compensation expense 424 428
Provision of income taxes on non-GAAP adjustments 1,501 (5,575 )
Non-GAAP Net income $ 16,951 $ 16,362
GAAP diluted earnings (loss) per share $ 1.39 $ (0.18 )
Non-GAAP adjustments
Unrealized (gains)/losses on marketable equity securities (0.33 ) 0.76
Legal costs and charges related to Caris’ legal investigation 0.45
Operating results for newly opened facilities not at full capacity (2) 0.03 0.03
Stock-based compensation expense 0.02 0.02
Non-GAAP diluted earnings per share $ 1.11 $ 1.08

(2) The newly opened facilities for the 2019 period presented consist of facilities opened from 2017 through 2019 (one skilled nursing facility, two assisted living facilities, and one memory care facility). The newly opened facilities for the 2018 period presented consist of facilities opened from 2016 through 2018 (two skilled nursing facilities and three assisted living facilities).

View source version on businesswire.com: https://www.businesswire.com/news/home/20190510005029/en/

Related Posts:

  • No Related Posts

Talend SA (TLND) Expected to Post Earnings of -$0.30 Per Share

Crosslink Capital Inc. grew its position in Talend by 44.9% in the fourth quarter. Crosslink Capital Inc. now owns 652,064 shares of the technology …

Talend logoAnalysts forecast that Talend SA (NASDAQ:TLND) will report earnings per share (EPS) of ($0.30) for the current quarter, Zacks reports. Three analysts have issued estimates for Talend’s earnings, with estimates ranging from ($0.31) to ($0.30). Talend reported earnings per share of ($0.18) in the same quarter last year, which would suggest a negative year-over-year growth rate of 66.7%. The company is scheduled to issue its next earnings results after the market closes on Wednesday, May 8th.

On average, analysts expect that Talend will report full year earnings of ($0.90) per share for the current year, with EPS estimates ranging from ($0.92) to ($0.89). For the next financial year, analysts forecast that the company will report earnings of ($0.65) per share, with EPS estimates ranging from ($0.93) to ($0.50). Zacks’ EPS calculations are a mean average based on a survey of research firms that cover Talend.

Talend (NASDAQ:TLND) last posted its earnings results on Wednesday, May 8th. The technology company reported ($0.32) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.39) by $0.07. Talend had a negative return on equity of 123.26% and a negative net margin of 19.75%. The company had revenue of $57.84 million during the quarter, compared to the consensus estimate of $56.59 million. During the same quarter last year, the firm earned ($0.18) earnings per share. The company’s revenue was up 23.6% on a year-over-year basis.

A number of research firms have recently weighed in on TLND. KeyCorp reissued a “buy” rating and set a $65.00 target price on shares of Talend in a report on Wednesday. ValuEngine downgraded Talend from a “buy” rating to a “hold” rating in a report on Tuesday. BidaskClub downgraded Talend from a “hold” rating to a “sell” rating in a research note on Tuesday, April 30th. BTIG Research boosted their price target on Talend to $62.00 and gave the company a “buy” rating in a research note on Monday, March 25th. They noted that the move was a valuation call. Finally, Zacks Investment Research downgraded Talend from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 22nd. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. Talend has an average rating of “Hold” and a consensus price target of $64.83.

In related news, COO Laurent Bride sold 2,397 shares of the business’s stock in a transaction dated Friday, February 15th. The stock was sold at an average price of $46.00, for a total value of $110,262.00. Following the completion of the transaction, the chief operating officer now owns 138,626 shares of the company’s stock, valued at $6,376,796. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

A number of hedge funds have recently bought and sold shares of the stock. FMR LLC raised its stake in Talend by 50.2% in the fourth quarter. FMR LLC now owns 2,501,189 shares of the technology company’s stock valued at $92,744,000 after purchasing an additional 835,482 shares in the last quarter. Bank of New York Mellon Corp grew its position in Talend by 12.9% in the fourth quarter. Bank of New York Mellon Corp now owns 2,330,624 shares of the technology company’s stock valued at $86,420,000 after acquiring an additional 267,076 shares during the last quarter. Praesidium Investment Management Company LLC grew its position in Talend by 51.7% in the fourth quarter. Praesidium Investment Management Company LLC now owns 1,464,776 shares of the technology company’s stock valued at $54,314,000 after acquiring an additional 498,916 shares during the last quarter. Crosslink Capital Inc. grew its position in Talend by 44.9% in the fourth quarter. Crosslink Capital Inc. now owns 652,064 shares of the technology company’s stock valued at $24,179,000 after acquiring an additional 202,130 shares during the last quarter. Finally, Vista Equity Partners Management LLC grew its position in Talend by 147.6% in the fourth quarter. Vista Equity Partners Management LLC now owns 625,579 shares of the technology company’s stock valued at $23,196,000 after acquiring an additional 372,916 shares during the last quarter. 79.90% of the stock is owned by institutional investors and hedge funds.

Shares of TLND traded up $0.87 during midday trading on Thursday, reaching $49.10. 377,025 shares of the stock were exchanged, compared to its average volume of 403,176. Talend has a twelve month low of $31.35 and a twelve month high of $73.52. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.72 and a current ratio of 0.72. The company has a market capitalization of $1.43 billion, a P/E ratio of -40.25 and a beta of 0.20.

Talend Company Profile

Talend SA provides software platform to address IT integration needs in various industries in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It designs and develops Talend Data Fabric, a software platform that integrates data and applications in real time across big data and cloud environments, as well as traditional systems, which allows organizations to develop a unified view of their business and customers.

Read More: Net Income

Get a free copy of the Zacks research report on Talend (TLND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Talend Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Talend and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts